FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3198410084> ?p ?o ?g. }

• W3198410084 endingPage "2184" @default.
• W3198410084 startingPage "2176" @default.
• W3198410084 abstract "DM and clinically amyopathic DM (CADM) patients with positive expression of anti-transcription intermediary factor 1-γ (anti-TIF1-γ) antibody (Ab) are characterized by distinct clinicopathological features. We aimed to determine the role of cytokine/chemokine profiles in the classification of anti-TIF1-γ positive DM/CADM patients.Serum levels of 24 cytokines/chemokines were measured in 27 anti-TIF1-γ positive DM/CADM patients by a Luminex 200 system. Principal components analysis and unsupervised hierarchical clustering were used to reduce variables and establish patient subgroups. Spearman's correlation coefficient was calculated between cytokine/chemokine levels and disease activity markers.Among anti-TIF1-γ positive DM/CADM patients, two distinct patient clusters were identified. The diagnosis of CADM was more common in cluster 1 than in cluster 2 (58.3% vs 6.7%, P = 0.008). Skin disease activity was higher in cluster 2 than in cluster 1 as measured by Cutaneous DM Disease Area and Severity Index-Activity [38.6 (10.4) vs 25.3 (10.0), P = 0.003]. Patients within cluster 2 exhibited significant muscle weakness (Medical Research Council scale ≤ 3, 33.3% vs 0.0%, P = 0.047), higher levels of anti-TIF1-γ Ab [92.4 (20.6) vs 66.9 (13.9), P = 0.001] and an increased malignancy rate (73.3% vs 25.0%, P = 0.021). Cluster 2 exhibited higher serum levels of CXCL10 [564.2 (258.8) vs 122.0 (97.8), P < 0.001], CCL2 [1136.6 (545.4) vs 441.6 (163.3), P < 0.001], galectin-9 [38879.6 (20009.3) vs 12612.4 (6640.0), P < 0.001], IL-18 [436.1 (188.9) vs 243.0 (114.5), P = 0.003], TNF-α [9.3 (3.8) vs 5.6 (2.4), P = 0.007] and TNFRI [1385.1 (338.2) vs 2605.6 (928.5), P < 0.001] than cluster 1.In anti-TIF1-γ positive DM/CADM, we identified a 'skin-predominant' cluster and a 'hyperinflammation' cluster based on the cytokine/chemokine profiles.Cytokine/chemokine profiles in anti-TIF1-γ positive DM/CADM can identify discrete clusters of patients with different disease patterns, organ involvements and clinical outcomes." @default.
• W3198410084 created "2021-09-13" @default.
• W3198410084 creator A5002430973 @default.
• W3198410084 creator A5015372940 @default.
• W3198410084 creator A5019560977 @default.
• W3198410084 creator A5021246506 @default.
• W3198410084 creator A5028464213 @default.
• W3198410084 creator A5036139505 @default.
• W3198410084 creator A5037008273 @default.
• W3198410084 creator A5073994967 @default.
• W3198410084 creator A5082921671 @default.
• W3198410084 creator A5088404273 @default.
• W3198410084 date "2021-09-11" @default.
• W3198410084 modified "2023-10-15" @default.
• W3198410084 title "Identification of distinct cytokine/chemokine profiles in dermatomyositis with anti-transcriptional intermediary factor 1-γ antibody" @default.
• W3198410084 cites W1541812013 @default.
• W3198410084 cites W1835542098 @default.
• W3198410084 cites W184510336 @default.
• W3198410084 cites W1984478297 @default.
• W3198410084 cites W2044606833 @default.
• W3198410084 cites W2048592275 @default.
• W3198410084 cites W2072335655 @default.
• W3198410084 cites W2094975067 @default.
• W3198410084 cites W2158020609 @default.
• W3198410084 cites W2169040326 @default.
• W3198410084 cites W2169176766 @default.
• W3198410084 cites W2170143274 @default.
• W3198410084 cites W2314311014 @default.
• W3198410084 cites W2460617447 @default.
• W3198410084 cites W2521592761 @default.
• W3198410084 cites W2769178448 @default.
• W3198410084 cites W2772233782 @default.
• W3198410084 cites W2797549582 @default.
• W3198410084 cites W2891733474 @default.
• W3198410084 cites W2921179481 @default.
• W3198410084 cites W2924454566 @default.
• W3198410084 cites W2936606030 @default.
• W3198410084 cites W2975706098 @default.
• W3198410084 cites W2977559163 @default.
• W3198410084 cites W2982250711 @default.
• W3198410084 cites W3004798180 @default.
• W3198410084 cites W3007738892 @default.
• W3198410084 cites W3008629354 @default.
• W3198410084 cites W3013870859 @default.
• W3198410084 cites W3014858201 @default.
• W3198410084 cites W3041794603 @default.
• W3198410084 cites W3043808622 @default.
• W3198410084 cites W3048974945 @default.
• W3198410084 cites W3080907109 @default.
• W3198410084 cites W3087422243 @default.
• W3198410084 cites W3126435116 @default.
• W3198410084 cites W3138332839 @default.
• W3198410084 cites W3151375336 @default.
• W3198410084 doi "https://doi.org/10.1093/rheumatology/keab625" @default.
• W3198410084 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34508564" @default.
• W3198410084 hasPublicationYear "2021" @default.
• W3198410084 type Work @default.
• W3198410084 sameAs 3198410084 @default.
• W3198410084 citedByCount "3" @default.
• W3198410084 countsByYear W31984100842022 @default.
• W3198410084 countsByYear W31984100842023 @default.
• W3198410084 crossrefType "journal-article" @default.
• W3198410084 hasAuthorship W3198410084A5002430973 @default.
• W3198410084 hasAuthorship W3198410084A5015372940 @default.
• W3198410084 hasAuthorship W3198410084A5019560977 @default.
• W3198410084 hasAuthorship W3198410084A5021246506 @default.
• W3198410084 hasAuthorship W3198410084A5028464213 @default.
• W3198410084 hasAuthorship W3198410084A5036139505 @default.
• W3198410084 hasAuthorship W3198410084A5037008273 @default.
• W3198410084 hasAuthorship W3198410084A5073994967 @default.
• W3198410084 hasAuthorship W3198410084A5082921671 @default.
• W3198410084 hasAuthorship W3198410084A5088404273 @default.
• W3198410084 hasConcept C126322002 @default.
• W3198410084 hasConcept C13373296 @default.
• W3198410084 hasConcept C159654299 @default.
• W3198410084 hasConcept C164866538 @default.
• W3198410084 hasConcept C199360897 @default.
• W3198410084 hasConcept C203014093 @default.
• W3198410084 hasConcept C2776914184 @default.
• W3198410084 hasConcept C2778690821 @default.
• W3198410084 hasConcept C41008148 @default.
• W3198410084 hasConcept C71924100 @default.
• W3198410084 hasConcept C90924648 @default.
• W3198410084 hasConceptScore W3198410084C126322002 @default.
• W3198410084 hasConceptScore W3198410084C13373296 @default.
• W3198410084 hasConceptScore W3198410084C159654299 @default.
• W3198410084 hasConceptScore W3198410084C164866538 @default.
• W3198410084 hasConceptScore W3198410084C199360897 @default.
• W3198410084 hasConceptScore W3198410084C203014093 @default.
• W3198410084 hasConceptScore W3198410084C2776914184 @default.
• W3198410084 hasConceptScore W3198410084C2778690821 @default.
• W3198410084 hasConceptScore W3198410084C41008148 @default.
• W3198410084 hasConceptScore W3198410084C71924100 @default.
• W3198410084 hasConceptScore W3198410084C90924648 @default.
• W3198410084 hasFunder F4320321001 @default.
• W3198410084 hasFunder F4320321885 @default.
• W3198410084 hasIssue "5" @default.
• W3198410084 hasLocation W31984100841 @default.

• next